Announce Date | 07/31/2025 |
EPS Normalized Actual | $2.45 (Miss by $-0.08) |
EPS GAAP Actual | $2.45 (Miss by $-0.08) |
Revenue Actual | $2.1024B |
Revenue Surprise | Beat by $2102.4M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $3.15 |
EPS GAAP Estimate | $3.15 |
Revenue Estimate | $2.285525B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 11.79629 | 24.29 | 10.68629 | 13.03797 | 1 |
Dec 2026 | 11.41667 | 25.1 | 11.18 | 11.65 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.44 | -0.6 | 2.1024B | 4.19% | -212.62M |
FQ1 2025 (Mar 2025) | 0.98 | -0.08625 | 1.6346B | 5.44% | -26.52M |
FQ4 2024 (Dec 2024) | 2.22 | -0.69331 | 1.8536B | 1.04% | -384.31M |
FQ3 2024 (Sep 2024) | 1.57 | 1.57 | 2.0039B | -9.08% | 2003.9M |
FQ2 2024 (Jun 2024) | 2.33 | 2.33 | 2.0144B | -4.89% | 2014.4M |
FQ1 2024 (Mar 2024) | 0.78 | 0.78 | 1.5457B | -6.68% | 1545.7M |
FQ4 2023 (Dec 2023) | 1.71 | 1.71 | 1.8343B | 5.58% | 1834.3M |
FQ3 2023 (Sep 2023) | 2.08 | 2.08 | 2.1858B | 4.46% | 2185.8M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
3.15
Consensus Revenue Estimates
2.285525B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.12135 | -- | 3.01183 | 3.42546 | 10 |
FQ2 2027 (Jun 2027) | 3.19076 | -- | 3.0788 | 3.50163 | 7 |
FQ1 2027 (Mar 2027) | 1.34365 | -- | 1.2965 | 1.47456 | 7 |
FQ4 2026 (Dec 2026) | 2.59 | -- | 2.4604 | 2.68625 | 5 |
FQ3 2026 (Sep 2026) | 3.35 | -- | 3.18237 | 3.4745 | 3 |
FQ2 2026 (Jun 2026) | 3.21 | 23.99 | 3.04938 | 3.32929 | 3 |
FQ1 2026 (Mar 2026) | 1.37 | 28.47 | 1.30145 | 1.42091 | 5 |
FQ4 2025 (Oct 2025) | 3.28889 | 32.5 | 3.09092 | 3.53774 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.48B | -- | 2.41B | 2.67B | 6 |
FQ2 2027 (Jun 2027) | 2.42B | -- | 2.35B | 2.6B | 6 |
FQ1 2027 (Mar 2027) | 1.82B | -- | 1.78B | 1.96B | 6 |
FQ4 2026 (Dec 2026) | 2.62B | -- | 2.52B | 2.7B | 6 |
FQ3 2026 (Sep 2026) | 2.55B | -- | 2.45B | 2.62B | 4 |
FQ2 2026 (Jun 2026) | 2.47B | 14.95 | 2.38B | 2.54B | 4 |
FQ1 2026 (Mar 2026) | 2.4B | 31.86 | 2.31B | 2.47B | 6 |
FQ4 2025 (Oct 2025) | 2.38B | 22 | 2.27B | 2.51B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.04 | 2.44 | -0.6 | -24.59% |
FQ1 2025 (Mar 2025) | 1.06625 | 0.98 | -0.08625 | -8.8% |
FQ4 2024 (Dec 2024) | 2.91331 | 2.22 | -0.69331 | -31.23% |
FQ3 2024 (Sep 2024) | 1.57 | 1.57 | 100% | |
FQ2 2024 (Jun 2024) | 2.33 | 2.33 | 100% | |
FQ1 2024 (Mar 2024) | 0.78 | 0.78 | 100% | |
FQ4 2023 (Dec 2023) | 1.71 | 1.71 | 100% | |
FQ3 2023 (Sep 2023) | 2.08 | 2.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.32B | $2.1B | $-212.62M | -10.11% |
FQ1 2025 (Mar 2025) | $1.66B | $1.63B | $-26.52M | -1.62% |
FQ4 2024 (Dec 2024) | $2.24B | $1.85B | $-384.31M | -20.73% |
FQ3 2024 (Sep 2024) | $0B | $2B | $2003.9M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.01B | $2014.4M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.55B | $1545.7M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.83B | $1834.3M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.19B | $2185.8M | 100% |